OPTIGLAZE
Device
GC America Inc.
Total Payments
$13,744
Transactions
34
Doctors
27
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $13.54 | 1 | 1 |
| 2023 | $4,074 | 7 | 4 |
| 2022 | $155.93 | 6 | 5 |
| 2021 | $1,792 | 5 | 4 |
| 2019 | $2,910 | 7 | 6 |
| 2018 | $4,033 | 6 | 6 |
| 2017 | $765.25 | 2 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $7,550 | 7 | 54.9% |
| Gift | $5,827 | 10 | 42.4% |
| Food and Beverage | $293.15 | 14 | 2.1% |
| Education | $73.84 | 3 | 0.5% |
Ad
Manufacturing Companies
- GC America Inc. $13,744
Product Information
- Type Device
- Total Payments $13,744
- Total Doctors 27
- Transactions 34
About OPTIGLAZE
OPTIGLAZE is a device associated with $13,744 in payments to 27 healthcare providers, recorded across 34 transactions in the CMS Open Payments database. The primary manufacturer is GC America Inc..
Payment data is available from 2017 to 2024. In 2024, $13.54 was paid across 1 transactions to 1 doctors.
The most common payment nature for OPTIGLAZE is "Honoraria" ($7,550, 54.9% of total).